Unusual treatment of Kasabach–Merritt syndrome secondary to hepatic hemangioma: embolization with bleomycin [Ungewöhnliche Behandlung eines Kasabach-Meritt Syndroms als Folge eines Hämangioms der Leber: Embolisation mit Bleomycin]
Küçük Resim Yok
Tarih
2015
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Springer-Verlag Wien
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Kasabach–Merritt syndrome (KMS) is a rare complication of cavernous hemangiomas characterized with anemia, thrombocytopenia, and consumption coagulopathy. This syndrome usually develops due to superficial soft tissue hemangiomas in infancy and childhood. KMS developing secondarily to hepatic hemangioma is very rare. In this report, we aimed to present the treatment of KMS developing secondarily to giant cavernous hemangioma of the liver with transarterial chemoembolization using bleomycin © 2014, Springer-Verlag Wien.
Açıklama
Anahtar Kelimeler
Bleomycin, Kasabach–Merritt syndrome, Lipiodol, Liver hemangiomas, Transarterial chemoembolization
Kaynak
Wiener Klinische Wochenschrift
WoS Q Değeri
Scopus Q Değeri
Q2
Cilt
127
Sayı
11.Dec
